Assessing the Pharmacokinetics of NKTR-118 in Subjects With Renal Impairment Compared to That in Subjects With Normal Renal Function

NCT01372826 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

Renal Impairment

Interventions

DRUG: NKTR118 Group1
DRUG: NKTR118 Group 2
DRUG: NKTR118 Group3
DRUG: NKTR118

Sponsor

AstraZeneca